Publication:
What predicts the recurrence in idiopathic granulomatous mastitis?

dc.contributor.authorLermi, Nihal
dc.contributor.authorEkin, Ali
dc.contributor.authorOcak, Tuğba
dc.contributor.authorBozkurt, Zeynep Yılmaz
dc.contributor.authorÖtegeçeli, Mehmet Akif
dc.contributor.authorYağız, Burcu
dc.contributor.authorCoşkun, Belkıs Nihan
dc.contributor.authorPehlivan, Yavuz
dc.contributor.authorDalkılıç, Ediz
dc.contributor.buuauthorLERMİ, NİHAL
dc.contributor.buuauthorEKİN, ALİ
dc.contributor.buuauthorOCAK, TUĞBA
dc.contributor.buuauthorBozkurt, Zeynep Yılmaz
dc.contributor.buuauthorÖTEGEÇELİ, MEHMET AKİF
dc.contributor.buuauthorYAĞIZ, BURCU
dc.contributor.buuauthorCOŞKUN, BELKIS NİHAN
dc.contributor.buuauthorPEHLİVAN, YAVUZ
dc.contributor.buuauthorDALKILIÇ, HÜSEYİN EDİZ
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentİç Hastalıkları Ana Bilim Dalı
dc.contributor.orcid0000-0003-3692-1293
dc.contributor.orcid0000-0003-3692-1293
dc.contributor.orcid0000-0002-7714-7786
dc.contributor.researcheridGXH-1905-2022
dc.contributor.researcheridJQW-5031-2023
dc.contributor.researcheridAAG-7155-2021
dc.contributor.researcheridFGB-0552-2022
dc.contributor.researcheridFPM-3131-2022
dc.contributor.researcheridIUR-9292-2023
dc.contributor.researcheridIUS-1387-2023
dc.contributor.researcheridIRX-3951-2023
dc.contributor.researcheridJHC-5173-2023
dc.date.accessioned2024-09-13T10:56:49Z
dc.date.available2024-09-13T10:56:49Z
dc.date.issued2023-06-10
dc.description.abstractIntroduction Idiopathic granulomatous mastitis (IGM) is a rarely seen chronic and benign disease of the breast. IGM usually emerges in women between 30 and 45 years of age and within the first 5 years after lactation. There is no consensus on the treatment of the disease. Steroids, immunosuppressive agents such as methotrexate and azathioprine, antibiotics, and surgical and conservative treatments can be preferred. In the present study, it was aimed to demonstrate the treatment options and follow-up data of the patients with IGM and to investigate the effective factors on recurrence if developed in the follow-up period.Materials and method The data of 120 patients diagnosed with idiopathic granulomatous mastitis were evaluated for this cross-sectional retrospective study. The demographic, clinical, treatment, and follow-up features of the patients were obtained from the file records.Results The median age value of the 120 female patients included in the study was 35 (24-67) years. Of the patients, 45%, 79.2%, 49.2%, and 15% had a past history of surgical intervention, steroid use, methotrexate use, and azathioprine use, respectively. Recurrent lesion developed after the treatment in 57 (47.5%) patients. The recurrence rate was 66.1% in the patients who underwent surgical intervention in the initial treatment. There was a statistically significant difference between the patients with and without recurrence regarding the presence of abscess, the presence of recurrent abscess, and having surgical intervention as the initial treatment in the past history. The rate of having surgery was statistically significantly higher compared with the administration of steroid therapy alone and the combination of steroid and immunosuppressive therapy in the initial treatment of the patients who developed recurrence. The rate of having surgery together with the administration of steroid and immunosuppressive therapy was statistically significantly higher than the administration of steroid and immunosuppressive therapies.Discussion Our study showed that surgical intervention and the presence of abscess increased recurrence in the treatment of IGM.
dc.identifier.doi10.1007/s10067-023-06651-3
dc.identifier.endpage2500
dc.identifier.issn0770-3198
dc.identifier.issue9
dc.identifier.startpage2491
dc.identifier.urihttps://doi.org/10.1007/s10067-023-06651-3
dc.identifier.urihttps://link.springer.com/article/10.1007/s10067-023-06651-3
dc.identifier.urihttps://hdl.handle.net/11452/44718
dc.identifier.volume42
dc.identifier.wos001006722600001
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherSpringer London Ltd
dc.relation.journalClinical Rheumatology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectSurgical-treatment
dc.subjectLobular mastitis
dc.subjectMethotrexate
dc.subjectExperience
dc.subjectManagement
dc.subjectDisease
dc.subjectUpdate
dc.subjectIdiopathic granulomatous mastitis
dc.subjectMethotrexate
dc.subjectRecurrence
dc.subjectSurgery
dc.subjectTreatment
dc.subjectRheumatology
dc.titleWhat predicts the recurrence in idiopathic granulomatous mastitis?
dc.typeArticle
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Romatoloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/İç Hastalıkları Ana Bilim Dalı
relation.isAuthorOfPublication7ab3d335-65f4-4ed0-9232-2cb5eece4f77
relation.isAuthorOfPublicationee3ea25a-1fdc-4876-b08e-2b6a76d20984
relation.isAuthorOfPublication6cb92e7a-17de-4006-944d-e9339a2b4591
relation.isAuthorOfPublication97e6fb0b-7225-43f7-8566-88e8486892aa
relation.isAuthorOfPublication02b3cfbb-e8e7-4a95-b025-294888ae9a91
relation.isAuthorOfPublicationfaabfe30-a620-4cbe-8b6d-3db71b10ce0e
relation.isAuthorOfPublication0075f2ae-ae8a-4690-bd46-128775e8efac
relation.isAuthorOfPublication1613225c-2f43-4052-9f82-210c854edcf4
relation.isAuthorOfPublication.latestForDiscovery7ab3d335-65f4-4ed0-9232-2cb5eece4f77

Files